We are entering a phase of more active clinical trials for neurodegenerative conditions like Parkinson’s, Alzheimer’s and other dementias. Some of these will be targeting symptoms, others will attempt to slow the disease.
We are entering a phase of more active clinical trials for neurodegenerative conditions like Parkinson’s, Alzheimer’s and other dementias. Some of these will be targeting symptoms, others will attempt to slow the disease.